Diabetes and obesity

ENDO 2022

Glucagon / GLP-1 agonist to treat obesity - a…

Sebastian Meyhöfer, MD

ENDO 2022

ANGPTL3 - New kid on the block?

Sebastian Meyhöfer, MD

ENDO 2022

Management of hyperglycemia for hospitalized patients

Sebastian Meyhöfer, MD

Transgender

ENDO 2022

Bone mineral density under GnRH agonists

Achim Wüsthof, MD

DSD / AGS

ENDO 2022

Complete androgen insensitivity syndrome: MRI screening…

Achim Wüsthof, MD

ENDO 2022

CRF1 receptor antagonist beneficial for adjustment of…

Achim Wüsthof, MD

Parathyroid

ENDO 2022

Update: Guideline on hypoparathyroidism 2022

Heide Siggelkow, MD

ENDO 2022

Update: Guideline on hyperparathyroidism 2022

Heide Siggelkow, MD

Neuroendocrinology and pituitary

ENDO 2022

Weight trajectory as a predictor of cushing’s disease

Ilonka Kreitschmann-Andermahr, MD

ENDO 2022

Addiction to wireless mobile device and obesity

Ilonka Kreitschmann-Andermahr, MD

ENDO 2022

Central diabetes insipidus from a patient's perspective

Ilonka Kreitschmann-Andermahr, MD

Calcium and bone

ENDO 2022

Iron and phosphate metabolism

Heide Siggelkow, MD